SCA
SGNT

SAC Capital Advisors’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

SAC Capital Advisors’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-142,700
Closed -$3.33M – 1453
2014
Q1 		$3.33M Buy
+142,700
New +$3.12M 0.02% 642
2013
Q4 		– Sell
-24,130
Closed -$492K – 2124
2013
Q3 		$492K Buy
24,130
+18,994
+370% +$423K ﹤0.01% 1153
2013
Q2 		$108K Buy
+5,136
New +$91.8K ﹤0.01% 1542

Other funds holding SGNT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return

SAC Capital Advisors's SGNT Position: Q2 2014 in Review

SAC Capital Advisors sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q2 2014, closing a stake of 142,700 shares — an estimated $3.33M sold.

SAC Capital Advisors first reported a position in SGNT in Q2 2013 and held it in 3 quarters. The position peaked at $3.33M in Q1 2014. 104 funds tracked by Wall St. Rank hold SGNT as of Q2 2014.

  • SAC Capital Advisors reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q2 2014 after selling out during the quarter.
  • SAC Capital Advisors sold 142,700 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q2 2014, an estimated $3.33M.
  • SAC Capital Advisors first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 3 quarters.
  • SAC Capital Advisors's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $3.33M in Q1 2014.
  • 104 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.